CCT244747, with the CAS number 1404095-34-6, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is classified as a small molecule inhibitor, specifically targeting certain kinases involved in various cellular processes. The compound is characterized by its unique molecular structure, which includes specific functional groups that contribute to its biological activity. CCT244747 has been studied for its efficacy in inhibiting tumor growth and may have implications in cancer treatment, particularly in cancers driven by specific genetic mutations. Its solubility, stability, and pharmacokinetic properties are critical for its development as a drug candidate. Additionally, ongoing research aims to elucidate its mechanism of action, optimize its efficacy, and assess its safety profile in preclinical and clinical settings. As with many investigational compounds, further studies are necessary to fully understand its potential benefits and limitations in therapeutic applications.

CCT244747

1404095-34-6: CCT244747, with the CAS number 1404095-34-6, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is classified as a small molecule inhibitor, specifically targeting certain kinases involved in various cellular processes. The compound is characterized by its unique molecular structure, which includes specific functional groups that contribute to its biological activity. CCT244747 has been studied for its efficacy in inhibiting tumor growth and may have implications in cancer treatment, particularly in cancers driven by specific genetic mutations. Its solubility, stability, and pharmacokinetic properties are critical for its development as a drug candidate. Additionally, ongoing research aims to elucidate its mechanism of action, optimize its efficacy, and assess its safety profile in preclinical and clinical settings. As with many investigational compounds, further studies are necessary to fully understand its potential benefits and limitations in therapeutic applications.

CCT244747 is a potent and selective CHK1 inhibitor oral, ATP-competitive, and cytotoxic, abrogating drug-induced S and G2 blockade and inducing apoptosis .

CAS 1404095-34-6

CCT244747

CCT244747

Ref: 54-BUP21823

CCT244747

Ref: TM-T14904

CCT244747

Ref: 7W-GW0047